RxDoctor Payments Data

Cameron Olezene, MD

Physical Medicine & Rehabilitation · Philadelphia, PANPI 1992235386

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,499 of the $4,040 with a category attached, or 61.9%. 7 manufacturers reported payments, led by Eisai Inc. at 46.8% of the total. Reporting peaked in 2024 at $3,378 and has fallen 97.6% since, to $80 in 2025. Among physical medicine & rehabilitation clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,040in general payments, 2019–2025

Across 31 payments — averaging $130.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$2K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Medtronic$329
  • Boston Scientific$201
  • F. Hoffmann-la Roche AG$134
  • Avanos Medical$26
  • plus $25 from 1 others
$4,190,333in research payments, 2019–2025

Across 131 payments — averaging $31,987 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1.5M
  • Janssen Research & Development, LLC$1.2M
  • E.r. Squibb & Sons, L.L.C.$633K
  • Eisai Inc.$537K
  • Genentech, Inc.$386K
  • Regeneron$1K

What the payments were for

  • Travel & lodging$2,49962%
  • Food & beverage$1,54138%

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,040 in reported general payments places this provider in the 90th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

See all physical medicine & rehabilitation providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$9,145
Medicare patients
67
Services billed
91

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine17$973
Gabapentin71$714
Pregabalin20$415
Tizanidine Hcl25$332
Cyclobenzaprine Hcl11$93
Meloxicam11$40

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →